Antarmitra Sembada is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1990. Antarmitra Sembada, a prominent player in the Indonesian pharmaceutical industry, was founded by a group of visionary entrepreneurs with a mission to enhance healthcare accessibility in Indonesia. The company focuses on the distribution and marketing of pharmaceutical products, medical devices, and consumer health products. Antarmitra Sembada operates a robust network of branches across Indonesia, ensuring a strong local presence and efficient distribution channels. The company is known for its diverse range of products, including prescription medications, over-the-counter drugs, and health supplements. Some of its well-known product brands include Antalgin, a popular pain reliever, and Vitacimin, a leading vitamin C supplement. In addition to its domestic operations, Antarmitra Sembada has expanded its reach to several Southeast Asian markets, establishing a growing international footprint. The company collaborates with various global pharmaceutical manufacturers and has formed strategic partnerships to enhance its product offerings and market reach. Antarmitra Sembada is a member of several industry associations, actively participating in initiatives to improve healthcare standards and regulations in Indonesia. The company is committed to sustainable business practices and aims to contribute positively to the communities it serves. With a vision to become a leading healthcare provider in the region, Antarmitra Sembada continues to innovate and expand its product portfolio, focusing on quality, safety, and customer satisfaction.
Headquarters
RT 005 RW 005
West Jakarta; Jakarta;
Postal Code: 11560
Contact Details: Purchase the PT Antarmitra Sembada report to view the information.
Website: http://www.ams.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service